August 8, 2023 — Although at greater risk, a new study found that patients of African ancestry with dilated cardiomyopathy (DCM) were less likely to have clinically actionable variants in DCM genes than those of European ancestry. LSU Health New Orleans is one of the 25 clinical sites nationally that enrolled participants in the study. Professor and Chief of Cardiology Dr. Frank Smart leads the LSU Health New Orleans site.

August 7, 2023 — The Society of Cardiovascular Computed Tomography (SCCT) presented three winners of the Best Abstract Awards — supported by the Cardiovascular Research Foundation of Southern California (CVRF of So.

August 7, 2023 — Biosense Webster, Inc., a global leader in cardiac arrhythmia treatment and part of Johns

August 3, 2023 — The cardiovascular polypill, developed by the Spanish National Centre for Cardiovascular Research (CNIC) and the pharmaceutical company 

August 2, 2023 — Teleflex Incorporated, a leading global provider of medical technologies, announced the U.S Food and Drug Administration (FDA) has cleared the QuikClot Control+ Hemostatic Device to include mild and moderate bleeding in cardiac surgical procedures and bone surface bleeding following a sternotomy. This allows clinicians to use the QuikClot Control+ Device to control all bleeding in cardiac surgical procedures.